“FDA Panel Votes to Remove Serious Warning from Pfizer’s Smoking Cessation Pill”

1
234

This week an FDA advisory panel decided to remove warnings of serious psychiatric side effects from the Chantix product label. “In making its recommendation, a US Food and Drug Administration advisory panel reviewed the results of a study that was released earlier this year and found that Chantix does not appear to increase the risk of suicidal behavior,” Ed Silverman reports for STAT. “An FDA medical review team had cast doubt on the study due to problems with collecting and analyzing side effect data as well as ties some investigators had to Pfizer.”

Article →  

chantix-fda

Support MIA

MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.

$
Select Payment Method
Personal Info

Credit Card Info
This is a secure SSL encrypted payment.

Billing Details

Donation Total: $20 One Time

1 COMMENT

  1. This is a shame, patients deserve informed consent. I declined to take Chantix, after watching a Chantix ad. And because I learned the hard way that Wellbutrin (same thing as Zyban) doesn’t help one quit smoking, and when one is then abruptly taken off Wellbutrin. Well, that causes antidepressant discontinuation syndrome symptoms, which all the mainstream and psychiatric doctors mistook for “bipolar.” Shame, also, that so few of the doctors know anything about the drugs they are prescribing. Especially, since they go around proclaiming they “know everything about the meds.”